Visceral and somatic sensory function in functional dyspepsia

Neurogastroenterology and Motility

Volumn 25, Issue 3, 2013, Pages

  Li, X ^a   Cao, Y ^a   Wong, R K M ^a,b   Ho, K Y ^a,b   Wilder Smith, C H ^a,c  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c Brain Gut Research Group   (Switzerland)

Author keywords

Functional dyspepsia; Functional gastrointestinal disorders; Sensitization; Sensory testing; Somatic pain; Visceral pain

Indexed keywords

CAPSAICIN; VANILLOID RECEPTOR 1;

ADULT; AGED; ARTICLE; CHEMOSENSITIZATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DYSPEPSIA; ELECTRIC HAND; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HEAT; HUMAN; MALE; NOCICEPTION; PAIN THRESHOLD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STIMULATION; STOMACH PAIN; VISCERAL PAIN; VISUAL ANALOG SCALE;

ADULT; AGED; CAPSAICIN; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; FOOT; HAND; HUMANS; IRRITANTS; MALE; MIDDLE AGED; PAIN; PAIN THRESHOLD; TRPV CATION CHANNELS; VISCERAL PAIN; YOUNG ADULT;

EID: 84874018529     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12044     Document Type: Article

References (72)

1. Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol 2007; 13: 3699-704.
2. Moshiree B, Zhou Q, Price DD, Verne GN. Central sensitisation in visceral pain disorders. Gut 2006; 55: 905-8.
3. Gwee KA, Chua AS. Functional dyspepsia and irritable bowel syndrome, are they different entities and does it matter?World J Gastroenterol 2006; 12: 2708-12.
4. Stanghellini V, Tosetti C, Paternico A et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-42.
5. Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol 2005; 39: S211-S216.
6. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil 2004; 16: 135-42.
7. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239-55.
8. Choung RS, Talley NJ. Novel mechanisms in functional dyspepsia. World J Gastroenterol 2006; 12: 673-7.
9. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep 2005; 7: 289-96.
10. Sarnelli G, Vandenberghe J, Tack J. Visceral hypersensitivity in functional disorders of the upper gastrointestinal tract. Dig Liver Dis 2004; 36: 371-6.
11. Bouin M, Meunier P, Riberdy-Poitras M, Poitras P. Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic condition?Dig Dis Sci 2001; 46: 2542-48.
12. Vandenbergh J, Dupont P, Fischler B et al. Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology 2005; 128: 564-73.
13. Lu CL, Wu YT, Yeh TC et al. Neuronal correlates of gastric pain induced by fundus distension: a 3T-fMRI study. Neurogastroenterol Motil 2004; 16: 575-87.
14. Vandenberghe J, Vos R, Persoons P, Demyttenaere K, Janssens J, Tack J. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways?Gut 2005; 54: 914-9.
15. Khoo J, Rayner CK, Feinle-Bisset C, Jones KL, Horowitz M. Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia. Neurogastroenterol Motil 2010; 22: 1270-8.
16. Bisschops R, Karamanolis G, Arts J et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 2008; 57: 1495-3.
17. Feinle-Bisset C, Horowitz M. Dietary factors in functional dyspepsia. Neurogastroenterol Motil 2006; 18: 608-18.
18. Schwartz MP, Samsom M, Smout AJ. Chemospecific alterations in duodenal perception and motor response in functional dyspepsia. Am J Gastroenterol 2001; 96: 2596-602.
19. Van Oudenhove L, McKie S, Lassman D et al. Fatty acid-induced gut-brain signaling attenuates neural and behavioral effects of sad emotion in humans. J Clin Invest 2011; 121: 3094-99.
20. Holzer P. TRP channels in the digestive system. Curr Pharm Biotechnol 2011; 12: 24-34.
21. Hammer J. Effect of repeated capsaicin ingestion on intestinal chemosensation and mechanosensation. Aliment Pharmacol Ther 2006; 24: 679-86.
22. Holzer P. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol 2004; 500: 231-41.
23. Rong W, Hillsley K, Davis JB, Hicks G, Winchester WJ, Grundy D. Jejunal afferent nerve sensitivity in wild-type and TRPV1 knockout mice. J Physiol 2004; 560: 867-81.
24. Gonlachanvit S, Mahayosnond A, Kullavanijaya P. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity. Neurogastroenterol Motil 2009; 21: 23-32.
25. Lee KJ, Vos R, Tack J. Effects of capsaicin on the sensorimotor function of the proximal stomach in humans. Aliment Pharmacol Ther 2004; 19: 415-25.
26. Hammer J. Hyperalgesia against capsaicin in persons with un-investigated dyspepsia: potential as a new diagnostic test. Wien Klin Wochenschr 2006; 118: 43-8.
27. Hammer J, Fuhrer M, Pipal L, Matiasek J. Hypersensitivity for capsaicin in patients with functional dyspepsia. Neurogastroenterol Motil 2008; 20: 125-33.
28. Drewes AM, Schipper KP, Dimcevski G et al. Gut pain and hyperalgesia induced by capsaicin: a human experimental model. Pain 2003; 104: 333-41.
29. Olesen AE, Staahl C, Brock C, Arendt-Nielsen L, Drewes AM. Evoked human oesophageal hyperalgesia: a potential tool for analgesic evaluation?Basic Clin Pharmacol Toxicol 2009; 105: 126-36.
30. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57: 923-9.
31. Pernia-Andrade AJ, Kato A, Witschi R et al. Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science 2009; 325: 760-4.
32. Kobayashi K, Fukuoka T, Obata K et al. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J Comp Neurol 2005; 493: 596-606.
33. Cao Y, Wilder-Smith CH, Li XH, Wong RK, Hammer J, Ho KY. Characterization of a reproducible gastric pain model using oral capsaicin titration in healthy volunteers. Neurogastroenterol Motil 2011; 23: e261-e270.
34. Dunphy RC, Bridgewater L, Price DD, Robinson ME, Zeilman CJ, III, Verne GN. Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms. Pain 2003; 102: 79-85.
35. Moshiree B, Price DD, Robinson ME, Gaible R, Verne GN. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain 2007; 23: 323-30.
36. Piche M, Arsenault M, Poitras P, Rainville P, Bouin M. Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome. Pain 2010; 148: 49-58.
37. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 2000; 356: 1154-9.
38. Wilder-Smith CH. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. Gut 2011; 60: 1589-99.
39. Van Oudenhove L, Vandenberghe J, Vos R, Holvoet L, Demyttenaere K, Tack J. Risk factors for impaired health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2011; 33: 261-74.
40. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20(Suppl 7): 31-9.
41. Coffin B. [Diagnosis of irritable bowel syndrome]. Gastroenterol Clin Biol 2009; 33(Suppl 1): S9-16.
42. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-90.
43. Moayyedi P, Duffett S, Braunholtz D et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998; 12: 1257-62.
44. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
45. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385-96.
46. Kang JY, Yeoh KG, Chia HP et al. Chili--protective factor against peptic ulcer?Dig Dis Sci 1995; 40: 576-9.
47. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?Pain 1997; 72: 95-97.
48. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
49. Naliboff BD, Munakata J, Fullerton S et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 505-12.
50. Chua SE, Cheung V, McAlonan GM et al. Stress and psychological impact on SARS patients during the outbreak. Can J Psychiatry 2004; 49: 385-90.
51. Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004; 53: 1595-601.
52. Song GH, Venkatraman V, Ho KY, Chee MW, Yeoh KG, Wilder-Smith CH. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain 2006; 126: 79-90.
53. Ladabaum U, Roberts TP, McGonigle DJ. Gastric fundic distension activates fronto-limbic structures but not primary somatosensory cortex: a functional magnetic resonance imaging study. Neuroimage 2007; 34: 724-32.
54. Larsson MB, Tillisch K, Craig AD et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 2012; 142: 463-72.
55. Van Oudenhove L, Vandenberghe J, Dupont P et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol 2010; 105: 913-24.
56. Tahara T, Shibata T, Nakamura M et al. Homozygous TRPV1 315C influences the susceptibility to functional dyspepsia. J Clin Gastroenterol 2010; 44: e1-e7.
57. Akbar A, Yiangou Y, Facer P et al. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 2010; 59: 767-74.
58. Fuhrer M, Vogelsang H, Hammer J. A placebo-controlled trial of an oral capsaicin load in patients with functional dyspepsia. Neurogastroenterol Motil 2011; 23: 918-e397.
59. Van Oudenhove L, Vandenberghe J, Geeraerts B et al. Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med 2007; 69: 455-63.
60. Sengupta JN. Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol 2009; 194: 31-74.
61. Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil 2008; 20(Suppl 1): 73-80.
62. Brumovsky PR, Gebhart GF. Visceral organ cross-sensitization - an integrated perspective. Auton Neurosci 2010; 153: 106-15.
63. Dahl JB, Kehlet H. Preventive analgesia. Curr Opin Anaesthesiol 2011; 24: 331-338.
64. Brumovsky PR, Gebhart GF. Visceral organ cross-sensitization - an integrated perspective. Auton Neurosci 2010; 153: 106-15.
65. Mayer EA. Spinal and supraspinal modulation of visceral sensation. Gut 2000; 47(Suppl 4): iv69-iv72.
66. Price DD, Craggs JG, Zhou Q, Verne GN, Perlstein WM, Robinson ME. Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. Neuroimage 2009; 47: 995-1001.
67. Chang L, Mayer EA, Johnson T, FitzGerald LZ, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000; 84: 297-307.
68. Bouin M, Lupien F, Riberdy M, Boivin M, Plourde V, Poitras P. Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation?Neurogastroenterol Motil 2004; 16: 311-4.
69. Hsu YC, Liou JM, Liao SC et al. Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria. Am J Gastroenterol 2009; 104: 2534-42.
70. Manabe N, Haruma K, Hata J et al. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable?Scand J Gastroenterol 2010; 45: 567-72.
71. Park JM, Choi MG, Cho YK et al. Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea. J Neurogastroenterol Motil 2011; 17: 279-86.
72. Tack J, Masaoka T, Janssen P. Functional dyspepsia. Curr Opin Gastroenterol 2011; 27: 549-57.